NanoStruct Raises €2.6 M Seed Round to Cut Food Pathogen Tests to Hours
NanoStruct raises €2.6 million to cut food bacterial testing from days to hours, targeting Listeria and Salmonella with nanotech sensors.

Read more
TL;DR
NanoStruct closed a €2.6 million seed round to launch pilot projects that shrink food‑borne pathogen testing from days to a few hours.
Context Würzburg‑based NanoStruct spun out of the University of Würzburg in 2021 to address a critical gap in food safety: the lag between sampling and pathogen identification. Conventional microbiology methods require 2–3 days, a window that can allow contaminated products to reach consumers before a recall.
Key Facts - The company raised €2.6 million in seed funding, led by High‑Tech Gründerfonds (HTGF), Bayern Kapital and the AUXXO Female Catalyst Fund. - CEO Dr Henriette Maaß praised the investors as “experienced, well‑networked, and convinced of our vision,” positioning them as partners for rapid market entry. - NanoStruct’s platform combines nanostructured sensor chips, optical measurement, biotechnology and machine‑learning analysis to detect Listeria, Salmonella and similar bacteria within a few hours. - The fresh capital will fund pilot deployments in the food‑analysis market, build a structured sales organization and expand the team. - Investment analyst Stephan Ruck highlighted the breakthrough in sensor technology and the company’s strong market network as reasons for backing the round.
What It Means If the pilot projects confirm the claimed speed, food manufacturers could receive same‑day test results, enabling immediate batch segregation and reducing recall costs. Faster detection also promises lower food waste, as producers can avoid discarding large quantities while awaiting lab results. Beyond food, the sensor platform could be adapted for veterinary diagnostics, human health testing and monitoring of bacterial contamination in sensitive manufacturing environments.
The next milestone will be the outcome of the pilot studies slated for the coming months. Successful validation could accelerate commercial rollout and set a new benchmark for microbial testing across multiple industries.
Continue reading
More in this thread
Conversation
Reader notes
Loading comments...